BoltzProt-1
Tamarind-hosted target-conditioned de novo protein binder design model.
Developer: BoltzProt-1 platform/model authors; Tamarind Bio hosting
Overview
- Developer
- BoltzProt-1 platform/model authors; Tamarind Bio hosting
- Category
- protein design
- Commercial rights
- Unverified
- License fee
- Unverified
- Open weights
- Unverified
- Last verified
- 2026-10-18
- Added
- 2026-10-18
Capabilities
Tamarind describes BoltzProt-1 as a de novo binder generator directed at a target protein. This is a different task from Boltz-2 complex/affinity prediction and should not inherit its reported accuracy, licensing or checkpoint status.
When to use it
Investigate new binder candidates through a hosted target-conditioned design flow; validate sequence properties and interface predictions with independent methods.
Compute
Compute category: hosted-service. See original installation instructions or platform terms for specific hardware costs and runtime.
Example use cases
- Investigate new binder candidates through a hosted target-conditioned design flow; validate sequence properties and interface predictions with independent methods.
Source-based workflow description. No experimental performance ranking is implied.
Known limitations
- Do not equate BoltzProt-1 binder-generation claims with Boltz-2 affinity prediction or measured KD. Platform cost and commercial rights not independently verified.
Check the original linked sources and the terms of every model dependency.
Commercial licensing
Commercial permission — Unverified
Tamarind-hosted method; underlying model weight and commercial rights unverified.
Do not equate BoltzProt-1 binder-generation claims with Boltz-2 affinity prediction or measured KD. Platform cost and commercial rights not independently verified.
Commercial fee — Unverified
No complete model + checkpoint + cloud compute + service charges have been verified. Public research software or downloadable weights do not imply a free commercial deployment.
Official references
Validate your designed binder.
Seq2Study coordinates expression, affinity, stability and developability testing for AI-designed antibodies and proteins.